CIK 0001652935 · <br>Emerging growth company
ACTUATE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ACTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473044785
- Phone
- 847-986-4190
- Business address
- 1751 RIVER RUN, SUITE 400, FORT WORTH, TX, 76107
- Open-market buys, last 90 days
- $50,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series B-3 Redeemable Convertible Preferred Stock | −44,559 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series B-4 Redeemable Convertible Preferred Stock | −309,589 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series B-4 Redeemable Convertible Preferred Stock | −2,022,029 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series B-4 Redeemable Convertible Preferred Stock | −326,547 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series B-4 Redeemable Convertible Preferred Stock | −2,094,650 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series C Redeemable Convertible Preferred Stock | −74,202 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series C Redeemable Convertible Preferred Stock | −484,638 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series C Redeemable Convertible Preferred Stock | −78,267 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Conversion · Series C Redeemable Convertible Preferred Stock | −573,394 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Option exercise · Warrant (Right to Buy) | −8,068 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Option exercise · Warrant (Right to Buy) | −26,355 | 0 | ||
| 2024-08-14 | Bios Equity COF, LP Director | Option exercise · Warrant (Right to Buy) | −3,528 | 0 | ||
| 2024-08-14 | Fletcher Aaron G.L. Director | Conversion | +884,427 | 884,427 | ||
| 2024-08-14 | Fletcher Aaron G.L. Director | Purchase | +375,000 | $8.00 | $3.0M | 1,259,427 |
| 2024-08-14 | Fletcher Aaron G.L. Director | Purchase | +125,000 | $8.00 | $1.0M | 125,000 |
| 2024-08-14 | Fletcher Aaron G.L. Director | Conversion | +525,797 | 525,797 | ||
| 2024-08-14 | Fletcher Aaron G.L. Director | Conversion | +307,538 | 307,538 | ||
| 2024-08-14 | Fletcher Aaron G.L. Director | Conversion | +141,457 | 141,457 | ||
| 2024-08-14 | Fletcher Aaron G.L. Director | Conversion | +462,073 | 462,073 | ||
| 2024-08-14 | Fletcher Aaron G.L. Director | Conversion | +61,857 | 61,857 |
Page 8 of 14 · 272 trades